Healios K.K. (4593.T)
JPY 181.0
(1.69%)
JPY 181.0
(1.69%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.53 Billion JPY | -36.58% |
| 2022 | 7.14 Billion JPY | -40.23% |
| 2021 | 11.95 Billion JPY | 4.85% |
| 2020 | 11.4 Billion JPY | -0.84% |
| 2019 | 11.5 Billion JPY | 326.08% |
| 2018 | 2.69 Billion JPY | 13.83% |
| 2017 | 2.37 Billion JPY | -5.16% |
| 2016 | 2.5 Billion JPY | 0.0% |
| 2015 | - JPY | 0.0% |
| 2014 | - JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 4.51 Billion JPY | -0.35% |
| 2024 Q2 | 6.09 Billion JPY | 35.05% |
| 2023 Q2 | 7.11 Billion JPY | -0.22% |
| 2023 Q4 | 4.53 Billion JPY | -36.14% |
| 2023 FY | 4.53 Billion JPY | -36.58% |
| 2023 Q3 | 7.09 Billion JPY | -0.21% |
| 2023 Q1 | 7.12 Billion JPY | -0.25% |
| 2022 Q3 | 7.16 Billion JPY | -42.04% |
| 2022 Q2 | 12.35 Billion JPY | 0.5% |
| 2022 Q1 | 12.29 Billion JPY | 2.85% |
| 2022 FY | 7.14 Billion JPY | -40.23% |
| 2022 Q4 | 7.14 Billion JPY | -0.24% |
| 2021 Q1 | 11.49 Billion JPY | 0.79% |
| 2021 FY | 11.95 Billion JPY | 4.85% |
| 2021 Q4 | 11.95 Billion JPY | 2.33% |
| 2021 Q2 | 11.58 Billion JPY | 0.81% |
| 2021 Q3 | 11.68 Billion JPY | 0.85% |
| 2020 Q1 | 10.66 Billion JPY | -7.25% |
| 2020 Q2 | 10.74 Billion JPY | 0.7% |
| 2020 Q3 | 10.81 Billion JPY | 0.73% |
| 2020 Q4 | 11.4 Billion JPY | 5.4% |
| 2020 FY | 11.4 Billion JPY | -0.84% |
| 2019 Q3 | 11.57 Billion JPY | 342.79% |
| 2019 FY | 11.5 Billion JPY | 326.08% |
| 2019 Q2 | 2.61 Billion JPY | -1.62% |
| 2019 Q1 | 2.65 Billion JPY | -1.59% |
| 2019 Q4 | 11.5 Billion JPY | -0.61% |
| 2018 FY | 2.69 Billion JPY | 13.83% |
| 2018 Q2 | 2.78 Billion JPY | 19.63% |
| 2018 Q4 | 2.69 Billion JPY | -1.57% |
| 2018 Q1 | 2.32 Billion JPY | -1.81% |
| 2018 Q3 | 2.74 Billion JPY | -1.54% |
| 2017 Q2 | 2.45 Billion JPY | -1.72% |
| 2017 Q3 | 2.41 Billion JPY | -1.75% |
| 2017 Q1 | 2.5 Billion JPY | 0.0% |
| 2017 Q4 | 2.37 Billion JPY | -1.78% |
| 2017 FY | 2.37 Billion JPY | -5.16% |
| 2016 FY | 2.5 Billion JPY | 0.0% |
| 2016 Q2 | 2.5 Billion JPY | 0.0% |
| 2016 Q1 | 2.5 Billion JPY | 0.0% |
| 2016 Q4 | 2.5 Billion JPY | 0.0% |
| 2016 Q3 | 2.5 Billion JPY | 0.0% |
| 2015 Q4 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2015 FY | - JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2014 FY | - JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 2.46 Billion JPY | -83.504% |
| PRISM BioLab Co.,LTD | - JPY | -Infinity% |
| GNI Group Ltd. | 3.69 Billion JPY | -22.505% |
| Linical Co., Ltd. | 3 Billion JPY | -50.971% |
| Trans Genic Inc. | 2.25 Billion JPY | -100.792% |
| MEDINET Co., Ltd. | 2.3 Million JPY | -196345.6% |
| Soiken Holdings Inc. | - JPY | -Infinity% |
| Cytori Cell Research Institute, Inc. | 2.47 Billion JPY | -83.351% |
| AnGes, Inc. | 362.67 Million JPY | -1149.604% |
| OncoTherapy Science, Inc. | 106.84 Million JPY | -4141.5% |
| Nxera Pharma Co., Ltd. | 73.97 Billion JPY | 93.873% |
| Immuno-Biological Laboratories Co., Ltd. | 235.98 Million JPY | -1820.485% |
| NanoCarrier Co., Ltd. | 1.1 Billion JPY | -308.687% |
| Carna Biosciences, Inc. | 182.97 Million JPY | -2376.895% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 885.12 Million JPY | -412.02% |
| RaQualia Pharma Inc. | 367.71 Million JPY | -1132.466% |
| Chiome Bioscience Inc. | 291 Million JPY | -1457.388% |
| Kidswell Bio Corporation | 2.57 Billion JPY | -76.0% |
| PeptiDream Inc. | 22.79 Billion JPY | 80.123% |
| Oncolys BioPharma Inc. | 315.17 Million JPY | -1337.954% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | 665 Million JPY | -581.504% |
| BrightPath Biotherapeutics Co., Ltd. | 112.5 Million JPY | -3928.444% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 142.85 Million JPY | -3072.492% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 97.54 Million JPY | -4546.204% |
| FunPep Company Limited | - JPY | -Infinity% |
| Kringle Pharma, Inc. | - JPY | -Infinity% |
| Stella Pharma Corporation | 933.3 Million JPY | -385.589% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | - JPY | -Infinity% |
| Cuorips Inc. | - JPY | -Infinity% |
| K Pharma,Inc. | - JPY | -Infinity% |
| Takara Bio Inc. | 968 Million JPY | -368.182% |
| ReproCELL Incorporated | - JPY | -Infinity% |
| PhoenixBio Co., Ltd. | 723.93 Million JPY | -526.027% |
| StemCell Institute Inc. | 8.78 Million JPY | -51493.807% |
| Japan Tissue Engineering Co., Ltd. | - JPY | -Infinity% |
| CellSeed Inc. | 151.25 Million JPY | -2896.364% |